Historical record - last NADAC effective date: 8/22/2018
Product Information
QC ANTI-DIARRHEAL 2 MG CAPLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.1204 per EA under NDC 63868033824. Its NADAC has been published 250 times since Nov 28, 2013.
FDA first approved this application on Dec 10, 1992.
Strength
2 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868033824
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/22/2018
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074091FDA Approved
12/10/1992
On Market Since
2/1/1993
Pharmacological Classes
Price Statistics
The NADAC for QC ANTI-DIARRHEAL 2 MG CAPLET has been published 250 times since Nov 28, 2013, and over the history we have for it it has risen 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1204 per EA |
|---|---|
| All-time high | $0.1234 (Mar 15, 2017) |
| All-time low | $0.1021 (Oct 21, 2015) |
| Median price | $0.1130 |
| Average price | $0.1121 |
| Largest weekly change | +14.6% (Jan 22, 2014) |
| Weeks tracked | 250 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+11.6%
Last surveyed Sep 5, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loperamide Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ANTI-DIARRHEAL 2 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for QC ANTI-DIARRHEAL 2 MG CAPLET, manufactured by Chain Drug Marketing Association, is $0.1204 per EA (NDC 63868033824), effective Sep 5, 2018.
How has the price of QC ANTI-DIARRHEAL 2 MG CAPLET changed over time?
Over the history we have for it, the NADAC for QC ANTI-DIARRHEAL 2 MG CAPLET has risen 11.6%. It has been tracked across 250 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QC ANTI-DIARRHEAL 2 MG CAPLET?
Since Nov 28, 2013, the NADAC for QC ANTI-DIARRHEAL 2 MG CAPLET has ranged from a low of $0.1021 (Oct 21, 2015) to a high of $0.1234 (Mar 15, 2017), with a median of $0.1130 per EA.
Are there cheaper alternatives to QC ANTI-DIARRHEAL 2 MG CAPLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC ANTI-DIARRHEAL 2 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures QC ANTI-DIARRHEAL 2 MG CAPLET?
QC ANTI-DIARRHEAL 2 MG CAPLET (NDC 63868033824) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.